Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 190 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
TUBB3
💬1. TUBB3
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection [10] Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, H ... | Brentuximab vedotin
Brentuximab vedotin
💬1. TUBB3
| Brentuximab vedotin | [2] 49 49, 51 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
TUBB4A
💬2. TUBB4A
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection [10] Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, H ... | Brentuximab vedotin
Brentuximab vedotin
💬2. TUBB4A
| Brentuximab vedotin | [2] 49 49, 51 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
TUBB4B
💬3. TUBB4B
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection [10] Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, H ... | Brentuximab vedotin
Brentuximab vedotin
💬3. TUBB4B
| Brentuximab vedotin | [2] 49 49, 51 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
CD52
💬4. CD52
| - | Alemtuzumab
Alemtuzumab
💬4. CD52
| Alemtuzumab | [22] 13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬4. CD52
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
TNFSF13B
💬5. TNFSF13B
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis [4] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Belimumab
Belimumab
💬5. TNFSF13B
| Belimumab | [13] 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬5. TNFSF13B
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
TNFSF13B
💬6. TNFSF13B
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis [4] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Atacicept
Atacicept
💬6. TNFSF13B
| Atacicept | [4] 13 13, 46, 49, 66 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
TNFSF13B
💬7. TNFSF13B
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis [4] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Tabalumab
Tabalumab
💬7. TNFSF13B
| Tabalumab | [2] 46 46, 49 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
TNFRSF13C
💬8. TNFRSF13C
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Human T-cell leukemia virus 1 infection, Primary immunodeficiency [5] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Ianalumab
Ianalumab
💬8. TNFRSF13C
| Ianalumab | [7] 35 35, 46, 49, 53, 61, 63, 95 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
CSF3R
💬9. CSF3R
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer [5] Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, ... | Filgrastim
Filgrastim
💬9. CSF3R
| Filgrastim | [35] 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 [35] 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 6 ... 9. CSF3R
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
ADRB2
💬10. ADRB2
| [9] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation [9] Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligan ... | Albuterol
Albuterol
💬10. ADRB2
| Salbutamol | [12] 3 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬10. ADRB2
|